Inventor · disambiguated record
Seiji Akamatsu
Also filed as: AKAMATSU SEIJI
13 granted patents·2 pending applications·90 citations·filing 1993–2012
90Inventor score
Top patents by PatentIndex Score
15 records- 0186US5464833AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1993·Granted Nov 7, 1995·33 cites·6 claims
- 0276US8263599B2STAT3/5 activation inhibitorSEKIGUCHI KAZUO·Filed 2007·Granted Sep 11, 2012·5 cites·6 claims
- 0376US8188277B2Aromatic compounds for suppressing the generation of collagenFUKUSHIMA TAE·Filed 2005·Granted May 29, 2012·6 cites·14 claims
- 0467US5672603AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Sep 30, 1997·20 cites·6 claims
- 0560US5723117AUse of interleukin-1 (IL-1) to inhibit development of hepatitisOTSUKA PHARMA CO LTD·Filed 1993·Granted Mar 3, 1998·20 cites·8 claims
- 0641US2012322807A1Stat3/5 activation inhibitorSEKIGUCHI KAZUO·Filed 2012·Application pending·0 cites
- 0740US2012238750A1Aromatic compoundFUKUSHIMA TAE·Filed 2012·Application pending·0 cites
- 0837US5925640AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Jul 20, 1999·2 cites·1 claims
- 0937US5691341AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Nov 25, 1997·1 cites·16 claims
- 1034US5872120AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Feb 16, 1999·1 cites·1 claims
- 1134US5798358AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Aug 25, 1998·1 cites·1 claims
- 1233US5543412AHepatitis treatment with carbostyril compoundsOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 6, 1996·1 cites·1 claims
- 1331US5916890AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1997·Granted Jun 29, 1999·0 cites·1 claims
- 1430US5750529AApoptosis regulating compostionOTSUKA PHARMA CO LTD·Filed 1995·Granted May 12, 1998·0 cites·2 claims
- 1530US5658912AApoptosis regulating compositionOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 19, 1997·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →